APA (7th ed.) Citation

Begümhan Demir Gündoğan, Fatih Sağcan, Sevcan Tuğ Bozdoğan, Yüksel Balcı, Ferah Tuncel Daloğlu, & Elvan Cağlar Çıtak. (2021). Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary Thyroid Carcinoma with Both NF1 and Homozygous RET Proto-oncogen Germ-line Mutations. Galenos Yayincilik.

Chicago Style (17th ed.) Citation

Begümhan Demir Gündoğan, Fatih Sağcan, Sevcan Tuğ Bozdoğan, Yüksel Balcı, Ferah Tuncel Daloğlu, and Elvan Cağlar Çıtak. Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary Thyroid Carcinoma with Both NF1 and Homozygous RET Proto-oncogen Germ-line Mutations. Galenos Yayincilik, 2021.

MLA (9th ed.) Citation

Begümhan Demir Gündoğan, et al. Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary Thyroid Carcinoma with Both NF1 and Homozygous RET Proto-oncogen Germ-line Mutations. Galenos Yayincilik, 2021.